logo

For the Inventor, By the Inventor

Dallas, TX, United States of America

Peloton Therapeutics, Inc.


USPTO Granted Patents = 18


Forward Citations = 118

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal John A Josey (13 out of 25 patents)

silverMedal Hanbiao Yang (13 out of 13 patents)

bronzeMedal Paul Wehn (12 out of 12 patents)

4.  Eli M Wallace (12 out of 91 patents)

5.  Bin Wang (11 out of 30 patents)

6.  James P Rizzi (11 out of 44 patents)

7.  Darryl David Dixon (9 out of 9 patents)

8.  Jonas Grina (9 out of 9 patents)

9.  Stephen T Schlachter (9 out of 51 patents)

10.  Rui Xu (9 out of 33 patents)

11.  Guangzhou Han (2 out of 2 patents)

12.  Karl Bedke (2 out of 2 patents)

13.  Xinlin Du (1 out of 1 patent)

14.  Barry Goggin (1 out of 1 patent)

15.  Peter J Stengel (1 out of 1 patent)


18 patents:

1. 12358870 - Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof (2025-07-15),
2. 12331068 - Compositions and methods for inhibiting CD73 (2025-06-17),
3. RE49948 - Aryl ethers and uses thereof (2024-04-30),
4. 11591355 - CD73 inhibitors and uses thereof (2023-02-28),
5. 10807948 - Aromatic compounds and uses thereof (2020-10-20),
6. 10786480 - Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof (2020-09-29),
7. 10597366 - Aryl ethers and uses thereof (2020-03-24),
8. 10512626 - Compositions for use in treating glioblastoma (2019-12-24),
9. 10335388 - Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof (2019-07-02),
10. 10278942 - Compositions for use in treating pulmonary arterial hypertension (2019-05-07),
11. 10155726 - Substituted pyridines and uses thereof (2018-12-18),
12. 10144711 - Aryl ethers and uses thereof (2018-12-04),
13. 10040767 - Benzimidazole derivatives and uses thereof (2018-08-07),
14. 9969689 - Aryl ethers and uses thereof (2018-05-15),
15. 9908845 - Aryl ethers and uses thereof (2018-03-06),
Company Overview
Peloton Therapeutics, Inc. is a biopharmaceutical company based in Dallas, Texas, focused on the discovery and development of innovative therapies for cancer and other serious diseases. The company specializes in precision medicine, leveraging its expertise in small molecule drug development to target specific biological pathways involved in tumor growth and survival. Peloton's research aims to address unmet medical needs through advanced therapeutic solutions, contributing to the evolving landscape of oncology treatment.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

18 Patents

#117 in Dallas, TX

#1,093 in Texas

#17,952 in US

#34,187 in the World

Dallas, TX (US)
Dallas, TX, United States of America

Peloton Therapeutics, Inc.

Forward Citations = 118

19 inventors:

goldMedal John A Josey (13 out of 25 patents)

silverMedal Hanbiao Yang (13 out of 13 patents)

bronzeMedal Paul Wehn (12 out of 12 patents)

4.  Eli M Wallace (12 out of 91 patents)

5.  Bin Wang (11 out of 30 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Peloton Therapeutics, Inc.. Retrieved from https://idiyas.com/company/peloton-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…